By IDSE News Staff
The FDA expanded the use of the 0.5-mL dose of Fluzone Quadrivalent (influenza vaccine, Sanofi Pasteur) to include children aged 6 through 35 months.
Sanofi Pasteur will have the 0.5-mL dose, in addition to the 0.25-mL dose, available for the upcoming 2019-2020 season for this expanded age range.
The approval is supported by clinical data from a phase 4 safety and immunogenicity study conducted in nearly 2,000 children, which demonstrated that one or two doses of 0.5 mL of